Patent Selections
Journal:
Recent Patents on Biomedical Engineering (Discontinued)
Volume:
2
Page:
157-160
Author(s):
Bentham Science Publishers
Epigenetic Variation and Customising Nutritional Intervention
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
7
Page:
115-124
Author(s):
L. R. Ferguson
Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
252-272
Author(s):
Csilla Ozvegy-Laczka, Csilla Hegedus, Gergely Szakacs and Balazs Sarkadi
Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
307-319
Author(s):
T. R. Wilson, P. G. Johnston and D. B. Longley
Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
320-340
Author(s):
Pepita Gimenez-Bonafe, Avelina Tortosa and Ricardo Perez-Tomas
A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
354-365
Author(s):
Britta Stordal and Ross Davey
Targeting Tumors Using Estrogen Receptor Ligand Conjugates
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
370-380
Author(s):
N. O. Keely and M. J. Meegan
Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
398-418
Author(s):
S. Germano and L. O'Driscoll
HER-2 Signaling and Inhibition in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
419-438
Author(s):
B. C. Browne, N. O'Brien, M. J. Duffy, J. Crown and N. O'Donovan
The Applicability of mTOR Inhibition in Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
439-450
Author(s):
I.R. H.M. Konings, J. Verweij, E. A.C. Wiemer and S. Sleijfer